Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Mark Perloe, M.D. Earns Distinguished 2017 Ricardo Azziz PCOS Challenge Advocacy Leadership Award
  • USA - English


News provided by

Shady Grove Fertility

Sep 19, 2017, 12:35 ET

Share this article

Share toX

Share this article

Share toX

Dr. Mark Perloe, founder of Georgia Reproductive Specialists
Dr. Mark Perloe, founder of Georgia Reproductive Specialists

Atlanta, GA (PRWEB) September 19, 2017 -- The award recognizes individuals who have demonstrated extraordinary dedication to advocacy and public policy efforts that expand access to resources and support for women and girls with polycystic ovary syndrome (PCOS), one of the most neglected, underfunded, and underdiagnosed areas of health.

I am deeply honored to receive this recognition & share this award with all of the men & women who advocate on behalf of those with PCOS

Post this

Dr. Perloe is a reproductive endocrinologist with over 30 years of extensive experience performing in vitro fertilization (IVF) and treating conditions related to infertility including PCOS, recurrent pregnancy loss, menstrual disorders, fibroids, and endocrine and other reproductive health problems. Dr. Perloe has served as principal investigator in numerous reproductive health research studies including innovative IVF treatments, ovulation induction, and polycystic ovary syndrome. He has published research in medical journals including Obstetrics & Gynecology, Southern Medical Journal, Human Reproduction, and the International Journal of Obstetrics and Gynecology. Dr. Perloe is the co-author of Miracle Babies and Other Happy Endings for Couples with Fertility Problems and is the creator of IVF.com.

Most recently, Dr. Perloe, who founded Georgia Reproductive Specialists—the third largest IVF practice in the Greater Atlanta region—in 2000, and fellow (GRS) physicians and team members joined forces with Shady Grove Fertility (SGF), which has 25 locations throughout Maryland, Pennsylvania, Virginia, and Washington, D.C. Combining the successful clinical, scientific, and operational approaches of SGF and GRS under the brand SGF Atlanta, provides an exceptional opportunity to bring enhanced fertility services to more patients in Atlanta and surrounding areas.

"Dr. Perloe is one of the country's leading physician-advocates for women and girls with PCOS and a shining example for other healthcare providers. He has been our champion and a true supporter since PCOS Challenge expanded to Atlanta," says Sasha Ottey, PCOS Challenge Executive Director. "Dr. Perloe was instrumental in the advent of the PCOS Awareness Symposium and was our first partner and sponsor of the event. He is a genuine PCOS advocate with vast knowledge about the disorder and the complex challenges that women with PCOS face. He dedicates much of his time to increasing PCOS awareness. We are pleased to present Dr. Perloe with this award and are excited about his continued commitment to work with us on legislative and community advocacy efforts to improve the lives of those with PCOS."

“I’ve had the distinct privilege of working with women and girls with PCOS throughout my career, as well as many people and organizations who have worked equally hard or harder to raise awareness within the community. I am deeply honored to receive this recognition and share this award with all of the men and women who advocate on behalf of those with PCOS. I look forward to continuing our efforts on behalf of those affected by PCOS to help them achieve a better quality of life and, for many, to help them conceive,” remarks Dr. Perloe.

About the Ricardo Azziz PCOS Challenge Advocacy Leadership Award
PCOS Challenge named the advocacy leadership award in honor of Dr. Ricardo Azziz, an international authority on polycystic ovary syndrome and one of the country's most impactful advocates for the PCOS patient community. For the past 25 years, Dr. Azziz has developed an internationally recognized research program which has been continuously funded by the National Institutes of Health, generated over 500 peer-reviewed articles, book chapters and reviews; over 300 abstracts and presentations at national meetings; and nine texts. Dr. Azziz has made major contributions to the field through his research and clinical work as well as his support and advocacy for PCOS patients. Dr. Azziz has been instrumental in enabling events like PCOS Challenge's Awareness Symposia to happen across the country, educating over 1,000 PCOS patients and healthcare professionals a year. PCOS Challenge recognizes the significance of Dr. Azziz's contributions to the PCOS movement with this award.

About SGF Atlanta
SGF Atlanta, formerly Georgia Reproductive Specialists (GRS), is part of the Shady Grove Fertility (SGF) international network of state-of-the-art infertility care and IVF centers, offering patients individualized care, innovative financial options, and pregnancy rates among the highest in the United States. SGF Atlanta offers a full range of reproductive medicine and fertility treatments, including diagnostic testing and treatment options from simple drug therapy and surgical procedures to assisted reproductive technologies (ART), for both men and women. The board certified physicians of SGF Atlanta offer more than 100 years of combined experience in reproductive medicine and infertility treatment and are experts in female and male reproductive disorders. The staff of over 40 includes skilled and experienced clinical and technical professionals, embryologists, counselors, and administrators who care for patients in Sandy Springs, Alpharetta, and Atlanta, GA. In addition, the renowned clinical laboratory staff of scientists is credited with developing cutting-edge techniques used by infertility specialists around the world. The SGF Atlanta on-site diagnostic laboratory is fully accredited and features the most advanced technology used in in vitro fertilization, thorough semen and hormone analysis, sperm preparation, and the assisted reproductive technologies. A personalized medical team, led by a board certified reproductive endocrinologist, ensures that patients receive the highest possible medical care, specialized support programs, educational resources, and financial management options. For more information about SGF Atlanta or to schedule an appointment with an SGF Atlanta physician, call 404-843-2229 or visit IVF.com. For more information about Shady Grove Fertility, call 1-888-761-1967 or visit ShadyGroveFertility.com.

Courtney Flantzer, Shady Grove Fertility, http://www.shadygrovefertility.com, +1 (202) 997-4515, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.